Finding the missing link between pancreatic neoplasia and carcinoma

Henry Ford Health System received a $714,934 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2028. The research initiative, titled "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma," is designed to advance understanding of pancreatic cancer development and progression through biomedical research aimed at improving healthcare outcomes for military service members and the general public.

The award supports hypothesis-driven research focused on identifying and characterizing the biological and pathological mechanisms that connect pancreatic neoplastic conditions to carcinoma development. As a non-profit integrated healthcare provider and research organization headquartered in Detroit, Michigan, Henry Ford Health System will leverage its established research infrastructure and scientific partnerships to deliver innovative research findings, diagnostic insights, and potential therapeutic approaches relevant to pancreatic cancer prevention and treatment. The three-year performance period aligns with standard Military Medical Research and Development program timelines and reflects DHA's commitment to funding advanced cancer research with direct applications to military medicine and public health.